lucemyra.com is a domain that was created on 2016-04-30,making it 8 years ago. It has several subdomains, such as hcp.lucemyra.com , among others.
Description:LUCEMYRA is the first & only FDA-approved, non-opioid, treatment for relief of multiple symptoms of opioid withdrawal after abrupt discontinuation in adults. Please visit for safety & Full...
Discover lucemyra.com website stats, rating, details and status online.Use our online tools to find owner and admin contact info. Find out where is server located.Read and write reviews or vote to improve it ranking. Check alliedvsaxis duplicates with related css, domain relations, most used words, social networks references. Go to regular site
HomePage size: 118.748 KB |
Page Load Time: 0.886894 Seconds |
Website IP Address: 141.193.213.21 |
BHG Staunton Opioid Addiction Treatment & Rehabilitation Center staunton.bhgrecovery.com |
Online Library for Opioid Stewardship - CaroNova Opioid Library opioidlibrary.caronova.org |
Non-Public Textbook Loan Form – Non-Public Textbooks textbooks.capitalregionboces.org |
Camel Water Treatment | Water Treatment Systems | Broomfield, CO denver.haguewater.com |
Acne Treatment Reviews | Best Acne Treatment for Your Skin acne-product.exposedskincare.com |
Opioid & Health Indicators Database opioid.amfar.org |
Dreamland Story - A fun, playable, and addictive Match 3 game | Don't play! It's addictive! download.dreamlandstory.com |
Opioid Conversions and Opioid Dosing Calculator opioidcalculator.practicalpainmanagement.com |
Families for Early Autism Treatment – FEAT is a non-profit, volunteer-driven organization of parents walk.feat.org |
trainingfadaaorg - Opioid Training Modules - Home Page bhcon.fadaa.org |
Opioid Withdrawal Treatment | LUCEMYRA (lofexidine) HCP hcp.lucemyra.com |
MHOA Opioid Toolkit - A Local Public Health Toolkit for Addressing the Opioid Epidemic | Just anothe opioid-toolkit.mhoa.com |
Knock Out Opioid Abuse knockoutday.drugfreenj.org |
Non-profit organization- Connect Us is a non-profit connectussports.playbookapi.com |
A Non-Addictive Opioid Withdrawal Treatment | LUCEMYRA ... https://lucemyra.com/ |
LUCEMYRA (lofexidine) HCP: Opioid Withdrawal Treatment https://hcp.lucemyra.com/ |
Savings - LUCEMYRA (lofexidine) https://lucemyra.com/savings/ |
FAQ - LUCEMYRA (lofexidine) https://lucemyra.com/faq/ |
Telemedicine - LUCEMYRA (lofexidine) https://lucemyra.com/telemedicine/ |
Safety Information https://hcp.lucemyra.com/safety/ |
Thank You - LUCEMYRA (lofexidine) https://lucemyra.com/thank-you/ |
Patient Resources - LUCEMYRA (lofexidine) https://lucemyra.com/patient-resources/ |
Savings Card - LUCEMYRA (lofexidine) https://lucemyra.com/savings-card/ |
Dosing | LUCEMYRA HCP https://hcp.lucemyra.com/dosing/ |
A lucemyra.com. 600 IN A 141.193.213.21 |
MX lucemyra.com. 3600 IN MX 10 mailstore1.secureserver.net. |
NS lucemyra.com. 3600 IN NS ns27.domaincontrol.com. |
SOA lucemyra.com. 600 IN SOA ns27.domaincontrol.com. dns.jomax.net. 2023070303 28800 7200 604800 600 |
Date: Mon, 13 May 2024 20:55:20 GMT |
Content-Type: text/html; charset=UTF-8 |
Transfer-Encoding: chunked |
Connection: keep-alive |
Vary: Accept-Encoding, Accept-Encoding, Accept-Encoding, Accept-Encoding,Cookie |
Link: https://lucemyra.com/wp-json/; rel="https://api.w.org/", https://lucemyra.com/wp-json/wp/v2/pages/81; rel="alternate"; type="application/json", https://lucemyra.com/; rel=shortlink |
X-Powered-By: WP Engine |
X-Cacheable: SHORT |
Cache-Control: max-age=600, must-revalidate |
X-Cache: HIT: 1 |
X-Cache-Group: normal |
CF-Cache-Status: DYNAMIC |
Server: cloudflare |
CF-RAY: 88358c8289910d4c-LAX |
alt-svc: h3=":443"; ma=86400 |
charset="utf-8"/ |
content="width=device-width, initial-scale=1, maximum-scale=1, user-scalable=0" name="viewport"/ |
content="#00c7b1" name="theme-color" |
content="http://lucemyra.com/wp-content/uploads/2018/07/Patient_TwitterCard_v2.jpg" name="twitter:image"/ |
content="http://lucemyra.com/wp-content/uploads/2018/07/Patient_OpenGraph_v2.jpg" property="og:image" |
content="2087986544774943" property="fb:app_id"/ |
content="E364C37A8BBD429A83A4A8E3C78F3EB7" name="msvalidate.01"/ |
content="app-id=1426460017" name="apple-itunes-app"/ |
content="index, follow, max-image-preview:large, max-snippet:-1, max-video-preview:-1" name="robots"/ |
content="LUCEMYRA is the first & only FDA-approved, non-opioid, treatment for relief of multiple symptoms of opioid withdrawal after abrupt discontinuation in adults. Please visit for safety & Full Prescribing Information" name="description"/ |
content="en_US" property="og:locale"/ |
content="website" property="og:type"/ |
content="Learn about LUCEMYRA (lofexidine)." property="og:title"/ |
content="Visit LUCEMYRA.com for safety and Full Prescribing Information" property="og:description"/ |
content="https://lucemyra.com/" property="og:url"/ |
content="LUCEMYRA (lofexidine)" property="og:site_name"/ |
content="2023-11-01T16:14:16+00:00" property="article:modified_time"/ |
content="https://lucemyra.com/wp-content/uploads/2023/10/PictogramPapersCheck.png" property="og:image"/ |
content="summary_large_image" name="twitter:card"/ |
content="Elementor 3.21.4; features: e_optimized_assets_loading, e_optimized_css_loading, additional_custom_breakpoints; settings: css_print_method-external, google_font-enabled, font_display-swap" name="generator"/ |
content="Powered by WPBakery Page Builder - drag and drop page builder for WordPress." name="generator" |
content="Powered by Slider Revolution 6.3.4 - responsive, Mobile-Friendly Slider Plugin for WordPress with comfortable drag and drop interface." name="generator"/ |
Ip Country: United States |
Latitude: 37.751 |
Longitude: -97.822 |
Important Safety Information Patient Prescribing Information For Healthcare Providers header Facebook page opens in new window X-Twitter page opens in new window Sign Up COVID-19 Information LUCEMYRA (lofexidine) Taking LUCEMYRA Patient Resources Savings FAQ Find a Provider Taking LUCEMYRA Patient Resources Savings FAQ Find a Provider Opioid withdrawal symptoms can block your path to recovery. LUCEMYRA® is the only FDA-approved, non-opioid medicine proven to help with symptoms of opioid withdrawal. Learn More Photos within this website are actor portrayals. LUCEMYRA can help relieve withdrawal symptoms Significantly improves the percentage of patients who successfully complete withdrawal treatment Demonstrated safety profile in studies Provides the biggest improvement in symptom relief when symptoms were often most severe Patient Resources See a collection of interactive and downloadable content, and links to external organizations See Resources LUCEMYRA PRESCRIPTION SAVINGS PROGRAM Eligible patients will pay $0* for LUCEMYRA. *See Terms and Conditions for details Learn More 2020 ASAM National Practice Guideline: Recommendations for Treating Opioid Withdrawal The American Society of Addiction Medicine (ASAM) recognizes two main strategies for managing opioid withdrawal: gradually tapering the dose of the current opioid(s), or using a non-opioid medication, like LUCEMYRA (lofexidine). Regarding the use of alpha-2 adrenergic agonists, the Guideline states: Lofexidine should therefore be the preferred choice for withdrawal management in an outpatient setting, where monitoring of blood pressure and management of hypotension is more difficult.” -American Society of Addiction Medicine, 2020 Get Started with LUCEMYRA Find a healthcare provider who can discuss treatment for opioid withdrawal symptoms with LUCEMYRA. Find a Provider Photos within this website are actor portrayals. EXPAND COLLAPSE Click to see full Important Safety Information & Prescribing Information What is LUCEMYRA? LUCEMYRA is a non-opioid prescription medicine used in adults to help with the symptoms of opioid withdrawal that may happen when you stop taking an opioid suddenly. LUCEMYRA will not completely prevent the symptoms of opioid withdrawal and is not a treatment for opioid use disorder. Important Safety Information LUCEMYRA can cause serious side effects, including low blood pressure, slow heart rate, and fainting. Watch for symptoms of low blood pressure or heart rate, including dizziness, lightheadedness, or feeling faint at rest or when quickly standing up; if you experience these symptoms, call your healthcare provider right away and do not take your next dose of LUCEMYRA until you have talked to your healthcare provider. Avoid becoming dehydrated or overheated and be careful not to stand up too suddenly from lying or sitting, as these may increase your risk of low blood pressure and fainting. When your treatment is complete, you will need to stop taking LUCEMYRA gradually, or your blood pressure could increase. After a period of not using opioid drugs, you can become more sensitive to the effects of opioids if you start using them again. This may increase your risk of overdose and death. Before taking LUCEMYRA, tell your healthcare provider about all your medical conditions, including if you have low blood pressure, slow heart rate, any heart problems including history of heart attack or a condition called long QT syndrome, liver or kidney problems, or if you drink alcohol. Tell your healthcare provider if you are pregnant, plan on becoming pregnant, or are breastfeeding; it is not known if LUCEMYRA can harm your unborn baby or whether LUCEMYRA passes into your breast milk. Especially tell your healthcare provider if you take benzodiazepines, barbiturates, tranquilizers, or sleeping pills, as taking these with LUCEMYRA can cause serious side effects. The most common side effects of LUCEMYRA include low blood pressure or symptoms of low blood pressure such as lightheadedness, slow heart rate, dizziness, sleepiness, and dry mouth. To report SUSPECTED ADVERSE REACTIONS or product complaints, contact US WorldMeds at 1-833-LUCEMYRA. You may also report SUSPECTED ADVERSE REACTIONS to the FDA at 1-800-FDA-1088 or www.fda.gov/medwatch. Click here to see full Prescribing Information .This website uses cookies so that we understand how you and other visitors use our website. You can learn more about the cookies we use in our privacy policy . Manage Cookies Reject All Accept All Manage consent Close Privacy Overview This website uses cookies to improve your experience while you navigate through the website. Out of these cookies, the cookies that are categorized as necessary are stored on . Necessary Necessary Always Enabled Necessary cookies are absolutely essential for the website to function properly. These cookies ensure basic functionalities and security features of the website, anonymously. Cookie Duration Description cookielawinfo-checkbox-analytics 11 months This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Analytics". cookielawinfo-checkbox-functional 11 months The cookie is set by GDPR cookie consent to record the user consent for the cookies in the category "Functional". cookielawinfo-checkbox-necessary 11 months This cookie is set by GDPR Cookie Consent plugin. The cookies is used to store the user consent for the cookies in the category "Necessary". cookielawinfo-checkbox-others 11 months This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Other. cookielawinfo-checkbox-performance 11 months This cookie is set by GDPR Cookie Consent plugin. The cookie is used to store the user consent for the cookies in the category "Performance". viewed_cookie_policy 11 months The cookie is set by the GDPR Cookie Consent plugin and is used to store whether or not user has consented to the use of cookies. It does not store any personal data. Functional functional Functional cookies help to perform certain functionalities like sharing the content of the website on social media platforms, collect feedbacks, and other third-party features. Performance performance Performance cookies are used to understand and analyze the key performance indexes of the website which helps in delivering a better user experience for the visitors. Analytics analytics Analytical cookies are used to understand how visitors interact with the website. These cookies help provide information on metrics the number of visitors, bounce rate, traffic source, etc. Advertisement advertisement Advertisement cookies are used to provide visitors with relevant ads and marketing campaigns. These cookies track visitors across websites and collect information to provide customized ads. Others others Other uncategorized cookies are those that are being analyzed and have not been classified into a category as yet. Save & Accept Contact Us | Privacy Policy | Terms of Use This product information is intended for US patients only. Any products discussed herein may have different product labeling in different countries. Under license from Britannia Pharmaceuticals Ltd. USWM, LLC is the exclusive licensee and distributor of LUCEMYRA in the United States and Its territories. ©2024. LUCEMYRA is a registered trademark of USWM, LLC. LUminate is a trademark of USWM, LLC. USWMLUC-00512 You are now leaving the LUCEMYRA Website, US WorldMeds is not responsible for the content on external websites. Close Agree X Want to learn more? Learn more about LUCEMYRA® and how it can help relieve the symptoms of opioid withdrawal after abrupt discontinuation. Sign up now to get more important information about LUCEMYRA, including advice for talking to your healthcare provider about making it a part of your opioid discontinuation plan. * Required Information Please enter your first name Please enter your...
Domain Name: LUCEMYRA.COM Registry Domain ID: 2025038092_DOMAIN_COM-VRSN Registrar WHOIS Server: whois.godaddy.com Registrar URL: http://www.godaddy.com Updated Date: 2024-05-01T17:48:36Z Creation Date: 2016-04-30T07:11:01Z Registry Expiry Date: 2025-04-30T07:11:01Z Registrar: GoDaddy.com, LLC Registrar IANA ID: 146 Registrar Abuse Contact Email: abuse@godaddy.com Registrar Abuse Contact Phone: 480-624-2505 Domain Status: clientDeleteProhibited https://icann.org/epp#clientDeleteProhibited Domain Status: clientRenewProhibited https://icann.org/epp#clientRenewProhibited Domain Status: clientTransferProhibited https://icann.org/epp#clientTransferProhibited Domain Status: clientUpdateProhibited https://icann.org/epp#clientUpdateProhibited Name Server: NS27.DOMAINCONTROL.COM Name Server: NS28.DOMAINCONTROL.COM DNSSEC: unsigned >>> Last update of whois database: 2024-05-17T21:14:50Z <<<